美国缺血性卒中患者30天再入院全国性估计
再通治疗与30天再入院风险降低相关(OR 0.82,95%CI 0.77-0.89)。
要点
- 缺血性卒中出院后30天再入院率为12.1%。
- 再入院中89.6%为非计划再入院,12.9%为潜在可预防。
- 再通治疗与30天再入院风险降低相关(OR 0.82)。
核心结论
- 约12%的缺血性卒中患者在出院后30天内再入院,再通治疗与30天再入院风险降低相关。
研究设计与样本
- 对2013年美国全国再入院数据库进行加权分析,代表全美住院情况。
主要发现
- 再入院中89.6%为非计划再入院,12.9%为潜在可预防。
- 超过20%的再入院归因于急性脑血管病。
- 再入院患者年龄更大且合并症负担更高。
- 控制年龄、性别、保险状态和合并症后,再通治疗与30天再入院风险降低相关(OR 0.82,95%CI 0.77-0.89)。
临床怎么用
- 再通治疗可能降低缺血性卒中患者30天再入院风险。
- 再入院多因急性脑血管病,需关注出院后早期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Readmission within 30 days of hospital discharge for ischemic stroke is an important quality of care metric. We aimed to provide nationwide estimates of 30-day readmission in the United States, describe important reasons for readmission, and sought to explore factors associated with 30-day readmission, particularly the association with recanalization therapy. METHODS: We conducted a weighted analysis of the 2013 Nationwide Readmission Database to represent all US hospitalizations. Adult patients with acute ischemic stroke including those who received intravenous tissue-type plasminogen activator and intra-arterial therapy were identified using International Classification of Diseases-Ninth Revision codes. Readmissions were defined as any readmission during the 30-day post-index hospitalization discharge period for the eligible patient population. Proportions and 95% confidence intervals for overall 30-day readmissions and for unplanned and potentially preventable readmissions are reported. Survey design logistic regression models were fit for determining crude and adjusted odds ratios and 95% confidence interval for association between recanalization therapy and 30-day readmission. RESULTS: Of the 319 317 patients with acute ischemic stroke, 12.1% (95% confidence interval, 11.9-12.3) were readmitted. Of these, 89.6% were unplanned and 12.9% were potentially preventable. More than 20% of all readmissions were attributable to acute cerebrovascular disease. Readmitted patients were older and had a higher comorbidity burden. After controlling for age, sex, insurance status, and comorbidities, patients who underwent recanalization therapy had significantly lower odds of 30-day readmission (odds ratio, 0.82; 95% confidence interval, 0.77-0.89). CONCLUSIONS: Up to 12% of patients with ischemic stroke get readmitted within 30 days post-discharge period, and recanalization therapy is associated with 11% to 23% lower odds of 30-day readmission.
引用
- Vahidy FS, Donnelly JP, McCullough LD, et al. Nationwide Estimates of 30-Day Readmission in Patients With Ischemic Stroke. Stroke. 2017. PMID: 28389607. doi:10.1161/STROKEAHA.116.016085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。